Prime Medicine (PRME) Amortizatization of Intangibles (2021 - 2026)

Prime Medicine (PRME) has 4 years of Amortizatization of Intangibles data on file, last reported at $675000.0 in Q1 2024.

• Quarterly Amortizatization of Intangibles rose 10.47% year-over-year to $675000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $3.5 million (up 229.41% YoY) and the FY2023 annual result came in at $3.4 million, up 1263.2% from the prior year.
• Amortizatization of Intangibles slipped to $675000.0 in Q1 2024, from $1.1 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q4 2023 to a low of -$715000.0 in Q4 2021.
• A 4-year average of $361800.0 and a median of $480500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 1514.29% — and 2024, when it increased 10.47%.
• Tracing PRME's Amortizatization of Intangibles over 4 years: stood at -$715000.0 in 2021, then surged by 148.95% to $350000.0 in 2022, then soared by 210.86% to $1.1 million in 2023, then sank by 37.96% to $675000.0 in 2024.
• The last three Amortizatization of Intangibles figures came in at $675000.0 (Q1 2024), $1.1 million (Q4 2023), and $917000.0 (Q3 2023), per Business Quant data.